Filing Details

Accession Number:
0001209191-20-025311
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-21 19:09:33
Reporting Period:
2020-04-21
Accepted Time:
2020-04-21 19:09:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614096 L. Jeffrey Ives C/O Cara Therapeutics, Inc.,
4 Stamford Plaza, 107 Elm Street
Stamford CT 06902
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-21 2,500 $9.94 8,500 No 4 M Direct
Common Stock Disposition 2020-04-21 2,500 $16.00 6,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-04-21 2,500 $0.00 2,500 $9.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,500 2025-06-08 No 4 M Direct
Footnotes
  1. This exercise and subsequent sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 15, 2019.
  2. Immediately exercisable.